702 related articles for article (PubMed ID: 22064361)
1. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis.
Rolo AP; Teodoro JS; Palmeira CM
Free Radic Biol Med; 2012 Jan; 52(1):59-69. PubMed ID: 22064361
[TBL] [Abstract][Full Text] [Related]
2. Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities.
Gambino R; Musso G; Cassader M
Antioxid Redox Signal; 2011 Sep; 15(5):1325-65. PubMed ID: 20969475
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.
Sanyal AJ; Campbell-Sargent C; Mirshahi F; Rizzo WB; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Clore JN
Gastroenterology; 2001 Apr; 120(5):1183-92. PubMed ID: 11266382
[TBL] [Abstract][Full Text] [Related]
4. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
[TBL] [Abstract][Full Text] [Related]
5. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease.
Nomura K; Yamanouchi T
J Nutr Biochem; 2012 Mar; 23(3):203-8. PubMed ID: 22129639
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial dysfunction in nonalcoholic steatohepatitis.
Serviddio G; Bellanti F; Vendemiale G; Altomare E
Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):233-44. PubMed ID: 21476918
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial involvement in non-alcoholic steatohepatitis.
Serviddio G; Sastre J; Bellanti F; Viña J; Vendemiale G; Altomare E
Mol Aspects Med; 2008; 29(1-2):22-35. PubMed ID: 18061659
[TBL] [Abstract][Full Text] [Related]
8. The role of oxidative stress in non-alcoholic steatohepatitis.
Koek GH; Liedorp PR; Bast A
Clin Chim Acta; 2011 Jul; 412(15-16):1297-305. PubMed ID: 21514287
[TBL] [Abstract][Full Text] [Related]
9. Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis.
Cusi K
Clin Liver Dis; 2009 Nov; 13(4):545-63. PubMed ID: 19818304
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease.
Sanyal AJ
Nat Clin Pract Gastroenterol Hepatol; 2005 Jan; 2(1):46-53. PubMed ID: 16265100
[TBL] [Abstract][Full Text] [Related]
11. Role of mitochondria in non-alcoholic fatty liver disease.
Pessayre D
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S20-7. PubMed ID: 17567459
[TBL] [Abstract][Full Text] [Related]
12. Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1/R2) and insulin receptor substrate isoforms (IRS-1/-2) of the liver in a nonalcoholic steatohepatitis animal model.
Matsunami T; Sato Y; Ariga S; Sato T; Shimomura T; Kashimura H; Hasegawa Y; Yukawa M
Metabolism; 2011 Jun; 60(6):805-14. PubMed ID: 20846698
[TBL] [Abstract][Full Text] [Related]
13. A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis.
Serviddio G; Bellanti F; Giudetti AM; Gnoni GV; Petrella A; Tamborra R; Romano AD; Rollo T; Vendemiale G; Altomare E
J Pharmacol Exp Ther; 2010 Mar; 332(3):922-32. PubMed ID: 20008062
[TBL] [Abstract][Full Text] [Related]
14. Curcumin ameliorates rabbits's steatohepatitis via respiratory chain, oxidative stress, and TNF-alpha.
Ramirez-Tortosa MC; Ramirez-Tortosa CL; Mesa MD; Granados S; Gil A; Quiles JL
Free Radic Biol Med; 2009 Oct; 47(7):924-31. PubMed ID: 19539747
[TBL] [Abstract][Full Text] [Related]
15. Inflammation in nonalcoholic steatohepatitis.
Harmon RC; Tiniakos DG; Argo CK
Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):189-200. PubMed ID: 21476914
[TBL] [Abstract][Full Text] [Related]
16. Fatty liver: role of inflammation and fatty acid nutrition.
Byrne CD
Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):265-71. PubMed ID: 20189787
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of disease progression in nonalcoholic fatty liver disease.
Jou J; Choi SS; Diehl AM
Semin Liver Dis; 2008 Nov; 28(4):370-9. PubMed ID: 18956293
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease.
Smith BW; Adams LA
Crit Rev Clin Lab Sci; 2011; 48(3):97-113. PubMed ID: 21875310
[TBL] [Abstract][Full Text] [Related]
19. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
Park SH
Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
[TBL] [Abstract][Full Text] [Related]
20. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites.
Neuschwander-Tetri BA
Hepatology; 2010 Aug; 52(2):774-88. PubMed ID: 20683968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
